Cardiovascular Disease Risk Factors Technology 
DAIC
APRIL 24, 2024
partially because its key risk factor, high blood pressure, is a ‘silent killer,’ and most patients have no symptoms before their first heart attack or stroke. Eighty percent of heart attacks and strokes are preventable. Yet, CVD remains the leading cause of death in the U.S.,
DAIC
JUNE 28, 2024
Getty Images milla1cf Fri, 06/28/2024 - 08:10 June 27, 2024 — Cardiovascular disease is the leading cause of death for women, and gaps in care and access persist between women and men. Addressing those gaps could lead to an increase of at least 1.6 million years of quality life and boost the U.S.
DAIC
JUNE 4, 2024
Caristo Diagnostics Limited has announced the results of a landmark clinical study published in The Lancet that support the ability of Caristo's CaRi-Heart AI technology to quantify coronary artery inflammation and accurately predict cardiac events. fold higher risk for cardiac mortality and 5.5-fold
Frontiers in Cardiovascular Medicine
JANUARY 15, 2024
Recently, the use of assisted reproductive technology (ART) has rapidly increased. Moreover, emerging evidence suggests an increased risk of cardiovascular disease (CVD) in offspring conceived using ART. As a result, an increasing number of people are concerned about the safety of offspring produced through ART.
DAIC
JANUARY 25, 2024
Getty Images milla1cf Thu, 01/25/2024 - 20:44 January 25, 2024 — Agepha Pharma , a leading multinational pharmaceutical company with the first FDA-approved anti-inflammatory cardiovascular treatment ( LODOCO – colchicine, 0.5 mg tablets for therapeutic intervention. mg tablets.”
DAIC
DECEMBER 9, 2023
However, conversations are ongoing around best practices and standards of care regarding contrast management and treatment for those with higher risk factors, like compromised renal function. Determine incidence of disease along with long term patient and economic implications.
DAIC
JULY 18, 2024
Kolossváry added, “The PRE-VUE registry will empower us to see the true additive value of CT-derived, histologically validated plaque volumes in predicting future adverse cardiovascular events.” 2017 23, April 2020; Available from: [link]. Hafiane, Vulnerable plaque, characteristics, detection, and potential therapies , J.
Expert insights. Personalized for you.
116 
Let's personalize your content